BioStock: BrainCool on the benefits of uplisting to Nasdaq First North

Medtech company BrainCool has long aspired to changing marketplace from Spotlight Stock Market to Nasdaq First North. The move would help attract institutional capital, among other key benefits. BioStock got in touch with BrainCool’s CEO Martin Waleij to discuss a list transfer, which he hopes can take place this quarter.

Read the interview with Martin Waleij at biostock.se:

https://www.biostock.se/en/2023/02/braincool-on-the-benefits-of-uplisting-to-nasdaq-first-north/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/